Glycogen phosphorylase inhibitors: a patent review (2008 – 2012)

Bibliography

• Nelson DL, Cox MMC. Lehninger principles of biochemistry. W.H. Freeman and Co, New York; 2008
   Google Scholar
• Roach PJ, Depaoli-Roach AA, Hurley TD, et al. Glycogen and its metabolism: some new developments and old themes. Biochem J 2012;441:763-87
   PubMed Web of Science ®Google Scholar
• Baker DJ, Greenhaff PI, Timmons JA. Glycogen phosphorylase inhibition as therapeutic target: a review of recent patent. Expert Opin Ther Patents 2006;16:459-66
   Web of Science ®Google Scholar
• Wang ZX. Kinetic study on the dimer-tetramer interconversion of glycogen phosphorylase a. Eur J Biochem 1999;259:609-17
   PubMedGoogle Scholar
• Jonhson LN. Glycogen phosphorylase: a multifaceted enzyme. Carlsberg Res Commun 1989;54:203-29
   PubMedGoogle Scholar
• Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylase: structure and function. Crit Rev Biochem Mol Biol 1989;24:69-99
   PubMed Web of Science ®Google Scholar
• Rath VL, Ammirati M, LeMotte PK, et al. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core. Mol Cell 2000;6:139-48
   PubMed Web of Science ®Google Scholar
• Johnson LN. Glycogen phosphorylase: control by phosphorylation and allosteric effectors. FASEB J 1992;6:2274-82
   PubMed Web of Science ®Google Scholar
• Rush JW, Spriet LL. Skeletal muscle glycogen phosphorylase a kinetics: effects of adenine nucleotides and caffeine. J Appl Physiol 2001;91:2071-8
   PubMed Web of Science ®Google Scholar
• Johnson LN, Barford D. Glycogen phosphorylase. The structural basis of the allosteric response and comparison with other allosteric proteins. J Biol Chem 1990;265:2409-12
   PubMedGoogle Scholar
• Oikonomakos NG, Skamnaki VT, Tsitsanou KE, et al. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure 2000;8:575-84
   PubMed Web of Science ®Google Scholar
• Loughlin WA. Recent advances in the allosteric inhibition of glycogen phosphorylase. Mini Rev Med Chem 2010;10:1139-55
   PubMedGoogle Scholar
• Krimm I, Lancelin J-M, Praly J-P. Binding evaluation of fragment-based scaffolds for probing allosteric enzymes. J Med Chem 2012;55:1287-95
   PubMedGoogle Scholar
• Barash V, Schramm H, Gutman A. Regulation of glycogen synthetase and phosphorylase phosphatase activities in rat adipose tissue. Biochim Biophys Acta 1977;481:86-95
   PubMedGoogle Scholar
• Chebotareva NA, Klinov SV, Kurganov BI. Regulation of muscle glycogen phosphorylase by physiological effectors. Biotechnol Genet Eng Rev 2001;18:265-97
   PubMedGoogle Scholar
• Bouscarel B, Exton JH. Regulation of hepatic glycogen phosphorylase and glycogen synthase by calcium and diacylglycerol. Biochim Biophys Acta 1986;888:126-34
   PubMedGoogle Scholar
• Kasvinsky PJ, Madsen NB, Sygusch J, et al. The regulation of glycogen phosphorylase alpha by nucleotide derivatives. Kinetic and x-ray crystallographic studies. J Biol Chem 1978;253:3343-51
   PubMed Web of Science ®Google Scholar
• Somsak L, Czifrak K, Toth M, et al. New inhibitors of glycogen phosphorylase as potential antidiabetic agents. Curr Med Chem 2008;15:2933-83
   PubMedGoogle Scholar
• Oikonomakos NG, Somsak L. Advances in glycogen phosphorylase inhibitor design. Curr Opin Investig Drugs 2008;9:379-95
   PubMedGoogle Scholar
• Chrysina ED. The prototype of glycogen phosphorylase. Mini Rev Med Chem 2010;10:1093-101
   PubMed Web of Science ®Google Scholar
• Chrysina ED, Chajistamatiou A, Chegkazi M. From structure–based to knowledge–based drug design through x-ray protein crystallography: sketching glycogen phosphorylase binding sites. Curr Med Chem 2011;18:2620-9
   PubMed Web of Science ®Google Scholar
• Hoover DJ, Lefkowitz-Snow S, Burgess-Henry JL, et al. Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase. J Med Chem 1998;41:2934-8
   PubMed Web of Science ®Google Scholar
• Purintrapiban J, Wang M, Forsberg NE. Identification of glycogen phosphorylase and creatine kinase as calpain substrates in skeletal muscle. Int J Biochem Cell Biol 2001;33:531-40
   PubMed Web of Science ®Google Scholar
• Browner MF, Fletterick RJ. Phosphorylase: a biological transducer. TIBS 1992;17:66-71
   PubMedGoogle Scholar
• Yorek MA, Blair JB, Ray PD. The influences of glucagon, epinephrine and adrenergic agents on glycogen phosphorylase a and pyruvate kinase activities in hepatocytes from juvenile and adult rabbits. Biochim Biophys Acta 1982;717:143-8
   PubMedGoogle Scholar
• Sprang S, Goldsmith E, Fletterick R. Structure of the nucleotide activation switch in glycogen phosphorylase a. Science 1987;237:1012-19
   PubMedGoogle Scholar
• Buchbinder JL, Fletterick RJ. Role of the active site gate of glycogen phosphorylase in allosteric inhibition and substrate binding. J Biol Chem 1996;271:22305-9
   PubMed Web of Science ®Google Scholar
• Palm D, Klein HW, Schinzel R, et al. The role of pyridoxal 5'-phosphate in glycogen phosphorylase catalysis. Biochemistry 1990;29:1099-107
   PubMedGoogle Scholar
• Withers SG, Shechosky S, Madsen NB. Pyridoxal phosphate is not the acid catalyst in the glycogen phosphorylase catalytic mechanism. Biochem Biophys Res Commun 1982;108:322-8
   PubMedGoogle Scholar
• Sprang SR, Goldsmith EJ, Fletterick RJ, et al. Catalytic site of glycogen phosphorylase: structure of the T state and specificity for alpha-D-glucose. Biochemistry-Us 1982;21:5364-71
   PubMed Web of Science ®Google Scholar
• Ekstrom JL, Pauly TA, Carty MD, et al. Structure-activity analysis of the purine binding site of human liver glycogen phosphorylase. Chem Biol 2002;9:915-24
   PubMed Web of Science ®Google Scholar
• Alemany S, Pelech S, Brierley CH, et al. The protein phosphatases involved in cellular regulation. Evidence that dephosphorylation of glycogen phosphorylase and glycogen synthase in the glycogen and microsomal fractions of rat liver are catalysed by the same enzyme: protein phosphatase-1. Eur J Biochem 1986;156:101-10
   PubMedGoogle Scholar
• Aiston S, Coghlan MP, Agius L. Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis. Eur J Biochem 2003;270:2773-81
   PubMedGoogle Scholar
• Ross SA, Gulve EA, Wang M. Chemistry and biochemistry of type 2 diabetes. Chem Rev 2004;104:1255-82
   PubMed Web of Science ®Google Scholar
• Liu Q, Chen L, Hu L, et al. Small molecules from natural sources, targeting signaling pathways in diabetes. Biochim Biophys Acta 2010;1799:854-65
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000;346:561-76
   PubMed Web of Science ®Google Scholar
• Pautsch A, Stadler N, Wissdorf O, et al. Molecular recognition of the protein phosphatase 1 glycogen targeting subunit by glycogen phosphorylase. J Biol Chem 2008;283:8913-18
   PubMedGoogle Scholar
• Torres TP, Fujimoto Y, Donahue EP, et al. Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in Zucker diabetic fatty rats. Diabetes 2011;60:2225-33
   PubMedGoogle Scholar
• Torres TP, Sasaki N, Donahue EP, et al. Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs. J Pharmacol Exp Ther 2011;337:610-20
   PubMedGoogle Scholar
• Lerin C, Montell E, Nolasco T, et al. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149. Biochem J 2004;378:1073-7
   PubMedGoogle Scholar
• Aiston S, Hampson L, Gόmez-Foix AM, et al. Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis. J Biol Chem 2001;276:23858-66
   PubMedGoogle Scholar
• Zhang L, Liu H. Novel therapeutics based on inhibiting the interaction of glycogen phosphorylase and GL-subunit of glycogen-associated protein phosphatase 1: WO2009127723. Expert Opin Ther Patents 2010;20:969-73
   PubMed Web of Science ®Google Scholar
• Zibrova D, Grempler R, Streicher RD, et al. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes. Biochem J 2008;412:359-66
   PubMedGoogle Scholar
• Boehringer Ingelheim International GMBH. Substituted arylsulfonylaminomethylphosphoric acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus. WO2009016119; 2009
   Google Scholar
• Inouye M, Oikawa A. Glycogen phosphorylase activities of tumors, regenerating rat liver and suckling rat liver. J Biochem 1961;49:303-6
   PubMedGoogle Scholar
• Mayer D, Seelmann-Eggebert G, Letsch I. Glycogen phosphorylase isoenzymes from hepatoma 3924A and from a non-tumorigenic liver cell line. Comparison with the liver and brain enzymes. Biochem J 1992;282(Pt 3):665-73
   PubMedGoogle Scholar
• Boyle P, Koechlin A, Pizot C, et al. Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis. Eur J Nutr 2012; [Epub ahead of print]
   Google Scholar
• Ros S, Schulze A. Linking glycogen and senescence in cancer cells. Cell Metab 2012;16:687-8
   PubMedGoogle Scholar
• Favaro E, Bensaad K, Chong MG, et al. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. Cell Metab 2012;16:751-64
   PubMed Web of Science ®Google Scholar
• Baker DJ, Timmons JA, Greenhaff PL. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes 2005;54:2453-9
   PubMed Web of Science ®Google Scholar
• Oikonomakos NG. Glycogen phosphorylase as a molecular target for type 2 diabetes therapy. Curr Protein Pept Sci 2002;3:561-86
   PubMed Web of Science ®Google Scholar
• Treadway JL, Mendys P, Hoover DJ. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Expert Opin Investig Drugs 2001;10:439-54
   PubMed Web of Science ®Google Scholar
• Tracey WR, Treadway JL, Magee WP, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol 2004;286:H1177-H84
   PubMed Web of Science ®Google Scholar
• Floettmann E, Gregory L, Teague J, et al. Prolonged inhibition of glycogen phosphorylase in livers of Zucker diabetic fatty rats models human glycogen storage diseases. Toxicol Pathol 2010;38:393-401
   PubMed Web of Science ®Google Scholar
• Somsak L. Glucose derived inhibitors of glycogen phosphorylase. C R Chem 2011;14:211-23
   Web of Science ®Google Scholar
• Martin JL, Veluraja K, Ross K, et al. Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. Biochemistry 1991;30:10101-16
   PubMed Web of Science ®Google Scholar
• Czifrak K, Kovacs L, Kover KE, et al. Synthesis of some derivatives of C-(1-deoxy-1-N-substituted-D-glucopyranosyl)formic acid (D-gluco-hept-2-ulopyranosonic acid) as potential inhibitors of glycogen phosphorylase. Carbohydr Res 2005;340:2328-34
   PubMedGoogle Scholar
• Czifrak K, Hadady Z, Docsa T, et al. Synthesis of N-(beta-D-glucopyranosyl) monoamides of dicarboxylic acids as potential inhibitors of glycogen phosphorylase. Carbohydr Res 2006;341:947-56
   PubMedGoogle Scholar
• Hadjiloi T, Tiraidis C, Chrysina ED, et al. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b. Bioorg Med Chem 2006;14:3872-82
   PubMedGoogle Scholar
• Oikonomakos NG, Tiraidis C, Leonidas DD, et al. Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition. J Med Chem 2006;49:5687-701
   PubMedGoogle Scholar
• Bertus P, Szymoniak J, Jeanneau E, et al. Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor. Bioorg Med Chem Lett 2008;18:4774-8
   PubMedGoogle Scholar
• Toth M, Kun S, Bokor E, et al. Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase. Bioorg Med Chem 2009;17:4773-85
   PubMed Web of Science ®Google Scholar
• Alexacou KM, Tenchiu Deleanu AC, Chrysina ED, et al. The binding of beta-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors. Bioorg Med Chem 2010;18:7911-22
   PubMed Web of Science ®Google Scholar
• Bokor E, Docsa T, Gergely P, et al. Synthesis of 1-(D-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors. Bioorg Med Chem 2010;18:1171-80
   PubMed Web of Science ®Google Scholar
• Tsirkone VG, Tsoukala E, Lamprakis C, et al. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: kinetic, crystallographic and modelling studies. Bioorg Med Chem 2010;18:3413-25
   PubMed Web of Science ®Google Scholar
• Nagy V, Felfoldi N, Konya B, et al. N-(4-Substituted-benzoyl)-N'-(beta-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods. Bioorg Med Chem 2012;20:1801-16
   PubMedGoogle Scholar
• Konya B, Docsa T, Gergely P, et al. Synthesis of heterocyclic N-(beta-D-glucopyranosyl)carboxamides for inhibition of glycogen phosphorylase. Carbohydr Res 2012;351:56-63
   PubMedGoogle Scholar
• Feuillastre S, Chajistamatiou AS, Potamitis C, et al. C-glucosylated malonitrile as a key intermediate towards carbohydrate-based glycogen phosphorylase inhibitors. Bioorg Med Chem 2012;20:5592-9
   PubMedGoogle Scholar
• Gimisis T. Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase. Mini Rev Med Chem 2010;10:1127-38
   PubMedGoogle Scholar
• Onda K, Suzuki T, Shiraki R, et al. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a. Bioorg Med Chem 2008;16:5452-64
   PubMed Web of Science ®Google Scholar
• Onda K, Shiraki R, Ogiyama T, et al. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Bioorg Med Chem 2008;16:10001-12
   PubMed Web of Science ®Google Scholar
• Xu Q, Huang L, Liu J, et al. Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes. Eur J Med Chem 2012;52:70-81
   PubMed Web of Science ®Google Scholar
• Torres TP, Sasaki N, Donahue EP, et al. Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs. J Pharmacol Exp Ther 2011;337:610-20
   PubMedGoogle Scholar
• Jakobs S, Fridrich D, Hofem S, et al. Natural flavonoids are potent inhibitors of glycogen phosphorylase. Mol Nutr Food Res 2006;50:52-7
   PubMedGoogle Scholar
• Kato A, Nasu N, Takebayashi K, et al. Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase. J Agric Food Chem 2008;56:4469-73
   PubMed Web of Science ®Google Scholar
• Hampson LJ, Arden C, Agius L, et al. Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site. Bioorg Med Chem 2006;14:7835-45
   PubMedGoogle Scholar
• Chen J, Gong Y, Liu J, et al. Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase. Chem Biodivers 2008;5:1304-12
   PubMedGoogle Scholar
• Cheng K, Zhang P, Liu J, et al. Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase. J Nat Prod 2008;71:1877-80
   PubMed Web of Science ®Google Scholar
• Li J, Lu Y, Su X, et al. A norsesquiterpene lactone and a benzoic acid derivative from the leaves of Cyclocarya paliurus and their glucosidase and glycogen phosphorylase inhibiting activities. Planta Med 2008;74:287-9
   PubMed Web of Science ®Google Scholar
• Zhu P, Bi Y, Xu J, et al. Terpenoids. III: synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorg Med Chem Lett 2009;19:6966-9
   PubMedGoogle Scholar
• Cheng K, Liu J, Sun H, et al. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase. Chem Biodivers 2010;7:690-7
   PubMed Web of Science ®Google Scholar
• Liang Z, Zhang L, Li L, et al. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies. Eur J Med Chem 2011;46:2011-21
   PubMed Web of Science ®Google Scholar
• Loughlin WA, Pierens GK, Petersson MJ, et al. Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitors. Bioorg Med Chem 2008;16:6172-8
   PubMed Web of Science ®Google Scholar
• Oikonomakos NG, Schnier JB, Zographos SE, et al. Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site. J Biol Chem 2000;275:34566-73
   PubMed Web of Science ®Google Scholar
• Kosmopoulou MN, Leonidas DD, Chrysina ED, et al. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex. Eur J Biochem 2004;271:2280-90
   PubMedGoogle Scholar
• Wen X, Sun H, Liu J, et al. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies. J Med Chem 2008;51:3540-54
   PubMed Web of Science ®Google Scholar
• Lu Z, Bohn J, Bergeron R, et al. A new class of glycogen phosphorylase inhibitors. Bioorg Med Chem Lett 2003;13:4125-8
   PubMed Web of Science ®Google Scholar
• Li YH, Coppo FT, Evans KA, et al. Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a. Bioorg Med Chem Lett 2006;16:5892-6
   PubMedGoogle Scholar
• Chen L, Li H, Liu J, et al. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Bioorg Med Chem 2007;15:6763-74
   PubMedGoogle Scholar
• Evans KA, Li YH, Coppo FT, et al. Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors. Bioorg Med Chem Lett 2008;18:4068-71
   PubMedGoogle Scholar
• Onda K, Shiraki R, Yonetoku Y, et al. Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors. Bioorg Med Chem 2008;16:8627-34
   PubMedGoogle Scholar
• Zhang L, Li H, Zhu Q, et al. Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase. Bioorg Med Chem 2009;17:7301-12
   PubMedGoogle Scholar
• Motoshima K, Ishikawa M, Sugita K, et al. Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists. Biol Pharm Bull 2009;32:1618-20
   PubMedGoogle Scholar
• Sparks SM, Banker P, Bickett DM, et al. Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups. Bioorg Med Chem Lett 2009;19:976-80
   PubMed Web of Science ®Google Scholar
• Sparks SM, Banker P, Bickett DM, et al. Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues. Bioorg Med Chem Lett 2009;19:981-5
   PubMed Web of Science ®Google Scholar
• Thomson SA, Banker P, Bickett DM, et al. Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: x-ray crystallographic characterization, core and urea optimization and in vivo efficacy. Bioorg Med Chem Lett 2009;19:1177-82
   PubMed Web of Science ®Google Scholar
• Hayes JM, Leonidas DD. Computation as a tool for glycogen phosphorylase inhibitor design. Mini Rev Med Chem 2010;10:1156-74
   PubMed Web of Science ®Google Scholar
• Osi Pharmaceuticals. Pyrrolidine-2-carboxilic Acid Amide Inhibitors of Glycogen Phosphorylase. WO2004104001; 2004
   Google Scholar
• Prosidion Ltd. Treatment of diabetes with Glycogen Phosphorylase Inhibitors. US20090298745; 2009
   Google Scholar
• Prosidion Ltd. Pyrrolopyridine-2-carboxilic Acid Hydrazides. US2008269277; 2008
   Google Scholar
• Prosidion Ltd. Indole-2-carboxilic Acid Hydrazides. US2008188472; 2008
   Google Scholar
• Prosidion Ltd. Pyrrolopyridine-2-carboxilic Acid Amide Inhibitors of Glycogen Phosphorylase. US8158622; 2012
   Google Scholar
• AstraZeneca AB. Heterocyclic Amide Derivatives which possess Glycogen Phosphorylase Inhibitory Activity. US20080064691; 2008
   Google Scholar
• Birch AM, Kenny PW, Oikonomakos NG, et al. Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors. Bioorg Med Chem Lett 2007;17:394-9
   PubMed Web of Science ®Google Scholar
• Whittamore PR, Addie MS, Bennett SN, et al. Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies. Bioorg Med Chem Lett 2006;16:5567-71
   PubMed Web of Science ®Google Scholar
• SmithKline Beecham Corp. Glycogen Phosphorylase Inhibitor Compound and Pharmaceuticals Composition Thereof. WO2009045830; 2009
   Google Scholar
• SmithKline Beecham Corp. Glycogen Phosphorylase Inhibitor Compound and Pharmaceutical Composition Thereof. WO2009045831; 2009
   Google Scholar
• Loxham SJG, Teague J, Poucher SM, et al. Glucagon challenge in the rat: a robust method for the in vivo assessment of Glycogen phosphorlyase inhibitor efficacy. J Pharmacol Toxicol Methods 2007;55:71-7
   PubMedGoogle Scholar
• Novartis AG. Anti-IL1-β antibody combination therapy. WO2010128092; 2010
   Google Scholar
• Docsa T, Czifrak K, Huse C, et al. Effect of glucopyranosylidene-spiro-thiohydantoin on glycogen metabolism in liver tissues of streptozotocin-induced and obese diabetic rats. Mol Med Rep 2011;4:477-81
   PubMedGoogle Scholar
• Abdel-Magid AF. GPR119 modulators for the treatment of diabetes, obesity, and related diseases. ACS Med Chem Lett 2012;3(12):955-8
   PubMedGoogle Scholar